持续性甲素耐药黄金葡萄球菌的30天死亡率 细菌病:从回顾性队列研究的见解
Minji Jeon1, Sukbin Jang2, Seok Jun Mun3,4
1Division of Infectious Diseases, Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea.
Yonsei medical journal
|November 28, 2024
概括
换用抗微生物药物治疗持久性甲素耐药黄金葡萄球菌 (MRSA) 细菌症并没有显著降低30天死亡率. 对于这种具有挑战性的感染,需要新的策略.
科学领域:
- 传染性疾病 传染性疾病
- 临床微生物学 临床微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲素耐药黄金葡萄球菌 (MRSA) 菌病是一种严重的感染,用糖为标准治疗方法.
- 持续的MRSA细菌病症是一个重大的临床挑战,需要对有效的治疗策略进行研究.
研究的目的:
- 为了研究持续的MRSA细菌病的真实世界抗菌治疗模式.
- 评估抗微生物药物切换对30天死亡率的影响.
- 为了确定与死亡率和抗微生物药物切换相关的因素,在持续的MRSA细菌病.
主要方法:
- 在四家医院 (2017-2021) 进行了116名患有持续MRSA细菌病的患者的回顾性分析.
- 使用时间依赖的考克斯回归分析来调整不朽时间偏差.
- 评估抗微生物药物的使用,切换频率和相关的临床因素.
主要成果:
- 37.1%的患者经历了抗微生物药物切换,通常是由于持续的细菌病.
- 在切换组中,未调整的30天死亡率较低 (21.4%对44.2%),但在调整不朽时间偏差后,这种差异并不显著 (aHR 0.24,p=0.238).
- 第4天的皮特细菌病评分和肺炎独立与30天死亡率相关;细菌病持续时间,初始提克波拉宁使用,心声图和查尔森并发症指数与切换有关.
结论:
- 在持续的MRSA细菌病症中切换抗菌剂并不能显著改善30天的生存率.
- 目前的治疗修改实践可能对这种患者群体不有效.
- 需要进一步的研究,以开发更有效的治疗策略,持续的MRSA bacteremia.
相关概念视频
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


